Insights

Market Engagement Neurelis actively participates in epilepsy awareness events such as Epilepsy Awareness Day and Sofie's Journey Expo, indicating a strong commitment to engaging with the epilepsy community and healthcare providers, which presents opportunities for targeted outreach and collaboration.

Innovative Therapeutics The company's focus on developing life-changing neurological therapeutics, including VALTOCO and investigational drugs like NRL-1049, aligns with the needs of healthcare providers seeking advanced treatment options, offering potential for partnerships or sales of related medical devices and services.

Growth & Funding With revenue estimated between 100M and 250M and secured funding of 114M, Neurelis demonstrates financial stability andgrowth potential, making it a viable client for strategic partnerships, research collaborations, or sales of technology solutions.

Technology Utilization Neurelis utilizes advanced digital tools such as NetSuite and Google Maps, suggesting a tech-savvy organization open to deploying innovative software solutions for operations, supply chain management, or customer engagement endeavors.

Leadership & Recognition The leadership's strategic focus and recent awards like the PM360 Gold Award highlight a forward-thinking company with a strong market presence, presenting an ideal opportunity for sales of consulting, promotional, or clinical support services tailored to dynamic pharmaceutical firms.

Neurelis, Inc. Tech Stack

Neurelis, Inc. uses 8 technology products and services including NetSuite, jQuery Migrate, Google Maps, and more. Explore Neurelis, Inc.'s tech stack below.

  • NetSuite
    E-commerce
  • jQuery Migrate
    Javascript Libraries
  • Google Maps
    Maps
  • PyScript
    Miscellaneous
  • Microsoft
    Miscellaneous
  • reCAPTCHA
    Security
  • ZURB Foundation
    UI Frameworks
  • Facebook
    Widgets

Media & News

Neurelis, Inc.'s Email Address Formats

Neurelis, Inc. uses at least 1 format(s):
Neurelis, Inc. Email FormatsExamplePercentage
FLast@neurelis.comJDoe@neurelis.com
98%
Last@neurelis.comDoe@neurelis.com
1%
F.Last@neurelis.comJ.Doe@neurelis.com
1%

Frequently Asked Questions

Where is Neurelis, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Neurelis, Inc.'s main headquarters is located at 3430 Carmel Mountain Road Suite 300 San Diego, California 92121 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Neurelis, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Neurelis, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neurelis, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Neurelis, Inc.'s official website is neurelis.com and has social profiles on LinkedInCrunchbase.

What is Neurelis, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Neurelis, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Neurelis, Inc. have currently?

Minus sign iconPlus sign icon
As of April 2026, Neurelis, Inc. has approximately 186 employees across 2 continents, including North AmericaEurope. Key team members include Cso, Neurelis, Inc: S. M.Chief Medical Officer: A. R.Vice President Of National Sales: S. J.. Explore Neurelis, Inc.'s employee directory with LeadIQ.

What industry does Neurelis, Inc. belong to?

Minus sign iconPlus sign icon
Neurelis, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Neurelis, Inc. use?

Minus sign iconPlus sign icon
Neurelis, Inc.'s tech stack includes NetSuitejQuery MigrateGoogle MapsPyScriptMicrosoftreCAPTCHAZURB FoundationFacebook.

What is Neurelis, Inc.'s email format?

Minus sign iconPlus sign icon
Neurelis, Inc.'s email format typically follows the pattern of FLast@neurelis.com. Find more Neurelis, Inc. email formats with LeadIQ.

How much funding has Neurelis, Inc. raised to date?

Minus sign iconPlus sign icon
As of April 2026, Neurelis, Inc. has raised $114M in funding. The last funding round occurred on Mar 10, 2021 for $114M.

When was Neurelis, Inc. founded?

Minus sign iconPlus sign icon
Neurelis, Inc. was founded in 2007.

Neurelis, Inc.

Pharmaceutical ManufacturingCalifornia, United States51-200 Employees

Neurelis, Inc., is dedicated to innovating life-changing therapeutics that help people with neurological conditions gain greater control over their journeys.

Section iconCompany Overview

Headquarters
3430 Carmel Mountain Road Suite 300 San Diego, California 92121 United States
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2007
Employees
51-200

Section iconFunding & Financials

  • $114M

    Neurelis, Inc. has raised a total of $114M of funding over 9 rounds. Their latest funding round was raised on Mar 10, 2021 in the amount of $114M.

  • $100M$250M

    Neurelis, Inc.'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $114M

    Neurelis, Inc. has raised a total of $114M of funding over 9 rounds. Their latest funding round was raised on Mar 10, 2021 in the amount of $114M.

  • $100M$250M

    Neurelis, Inc.'s revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

ยฉ LeadIQ, Inc. All rights reserved.